Varicella vaccination in children with steroid-sensitive nephrotic syndrome

Pediatric Nephrology

Volumn 17, Issue 3, 2002, Pages 181-183

  Alpay, Harika ^a   Yildiz, Nurdan ^b   Temizer, Hamiyet ^b   Özçay, Sevil ^b  

^a MARMARA UNIVERSITY   (Turkey)

^b SSK Goztepe Hospital   (Turkey)

Author keywords

Corticosteroids; Immunization; Nephrotic syndrome; Vaccines; Vericella zoster virus

Indexed keywords

LIVE VACCINE; STEROID; VARICELLA ZOSTER VACCINE; VIRUS ANTIBODY;

ANTIBODY DETECTION; ARTICLE; CHICKENPOX; CHILD; CHILD CARE; CLINICAL ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFICACY; DRUG RESPONSE; DRUG SAFETY; DRUG SENSITIVITY; FEMALE; FOLLOW UP; HERPES ZOSTER; HUMAN; IMMUNIZATION; MALE; NEPHROTIC SYNDROME; PRIORITY JOURNAL; RASH; RELAPSE; REMISSION; SEROCONVERSION; SEROLOGY; SINGLE DRUG DOSE; VACCINATION; VARICELLA ZOSTER VIRUS;

ADRENAL CORTEX HORMONES; CHICKENPOX; CHICKENPOX VACCINE; CHILD; CHILD, PRESCHOOL; FEMALE; HERPESVIRUS 3, HUMAN; HUMANS; IMMUNOCOMPROMISED HOST; MALE; NEPHROTIC SYNDROME; VACCINATION; VACCINES, INACTIVATED;

EID: 0036935630     PISSN: 0931041X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00467-001-0789-7     Document Type: Article

References (15)

1. Peter G (ed) (1997) Varicella zoster infections. Red book: report of the Committee on Infectious Diseases, 24th edn. American Academy of Pediatrics, pp, 573-585
2. Weller T (1983) Varicella and herpes zoster: changing concepts of the natural history, control and importance of not so benign virus. N Engl J Med 309:1362-1434
3. Morgan ER, Smalley LA (1983) Varicella in immunocompromised children. Am J Dis Child 137:883-885
4. Dowell JS, Bresee JS (1993) Severe varicella associated steroid use. Pediatrics 62:223-228
5. LaRussa P, Steinberg S, Gershon AA (1996) Varicella vaccine for immunocompromised children: results of collaborative studies in United States and Canada. J Infect Dis 174 [Suppl 3]:S320-S323
6. Gershon AA, Steinberg S, Gelb L (1984) NIAID Collaborative Varicella Vaccine Study Group. Live attenuated varicella vaccine: efficacy for children with leukemia in remission. JAMA 252:355-362
7. Quien RM, Kaiser BA, Deforest A, Polinsky MS, Fisher M, Baluarte HJ (1997) Response to the varicella vaccine in children with nephrotic syndrome. J Pediatr 131:688-690
8. Gershon A, Brunell P, Doyle EF, Claps A (1972) Steroid therapy and varicella. J Pediatr 81:1034
9. Steele RW (1994) Current status of vaccines and immunoglobulins for children with renal disease. Pediatr Nephrol 8:7-10
10. Weibel RE, Kuter BJ, Neff BJ, Rothenberger CA, Fitzgerald AJ, Connor KA, Morton D, McLean AA, Scolnick EM (1985) Live Oka/Merck varicella vaccine in healthy children. JAMA 254:2435-2439
11. Meurice F, Bouver JL, Vandevoorde D, Woods S, Bogaerts H (1996) Immunogenicity and safety of a live attenuated varicella vaccine (Oka/SB Bio) in healthy children. J Infect Dis 174 [Suppl 3]:S324-S329
12. Bernstein HH, Rothstein EP, Watson BM, Reisinger KS, Blatter MM, Wellman CO, Chartrand SA, Cho I, Ngai A, White CJ (1993) Clinical survey of natural varicella compared with breakthrough varicella after immunization with live attenuated Oka/Merck varicella vaccine. Pediatrics 92:833-837
13. Johnson C, Rome LP, Stancin T, Kumar ML (1989) Humoral immunity and clinical reinfections following varicella vaccine in healthy children. Pediatrics 84:418-421
14. Watson BM, Piercy SA, Plotkin SA, Starr SA (1993) Modified chickenpox in children immunized with the Oka/Merck varicella vaccine. Pediatrics 91:17-22
15. Schnaper HW (1994) Immunization practices in childhood nephrotic syndrome: a survey of North American pediatric nephrologists. Pediatr Nephrol 8:4-6